Literature DB >> 10502439

Evaluation of Langerhans' cells in the cervical epithelium of women with cervical intraepithelial neoplasia.

J P Connor1, K Ferrer, J P Kane, J M Goldberg.   

Abstract

OBJECTIVE: Cervical infection with human papillomavirus (HPV) results in a more permissive environment for malignant transformation. In squamous epithelia the Langerhans' cell (LC) is responsible for antigen presentation. Studies that use S-100 immunostaining demonstrate low LCs in cervical intraepithelial neoplasia (CIN) while those that use other methods have shown normal numbers of LCs. This observation led us to postulate that a defect in S-100 proteins, not a simple decrease in LC number, may be the cause of immune suppression. To evaluate this we identified LCs in the cervix of women with HPV/CIN in a prospective fashion using two antibodies, S-100 and CD1, each targeting a different element of the LC.
METHODS: Paired biopsies of the cervix were taken, one paraffin embedded for S-100 and the other snap frozen for CD1 staining. LCs were counted and expressed as the number of cells per millimeter of epithelium. Analysis of variance was used to assess differences between counts in normal, low-grade, and high-grade lesions. HPV was tested by hybrid capture.
RESULTS: S-100 LCs were significantly reduced in dysplasia, LG 8.6 and HG 6.0, compared to normal at 16.7 cells/mm (P = 0.04). S-100 LCs were reduced in HPV-infected cases at 5.9 vs 12.8 cells/mm in HPV negatives (P = 0.02). Acute inflammatory infiltrates were associated with increased S-100 LCs independent of pathology. CD1 LCs were not significantly altered by any parameters tested.
CONCLUSIONS: HPV/CIN may exert an immunosuppressive effect by decreasing the S-100 LCs. The association of S-100-positive LCs coupled with cervical inflammatory changes suggests an important function of the S-100 proteins in the development of an anti-HPV response. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10502439     DOI: 10.1006/gyno.1999.5559

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

Review 1.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

Review 2.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

Review 3.  Early Defensive Mechanisms against Human Papillomavirus Infection.

Authors:  Andrea Moerman-Herzog; Mayumi Nakagawa
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

4.  Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production.

Authors:  Jennifer C Guess; Dennis J McCance
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract.

Authors:  Rafael Jimenez-Flores; Rene Mendez-Cruz; Jorge Ojeda-Ortiz; Rebeca Muñoz-Molina; Oscar Balderas-Carrillo; Maria de la Luz Diaz-Soberanes; Serge Lebecque; Sem Saeland; Adrian Daneri-Navarro; Alejandro Garcia-Carranca; Stephen E Ullrich; Leopoldo Flores-Romo
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

Review 6.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

Review 7.  Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer.

Authors:  B Clarke; R Chetty
Journal:  Mol Pathol       Date:  2002-02

8.  Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein.

Authors:  Joanna Laurson; Sadaf Khan; Rachel Chung; Karen Cross; Kenneth Raj
Journal:  Carcinogenesis       Date:  2010-02-01       Impact factor: 4.944

9.  High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells.

Authors:  Norifumi Iijima; Edward C Goodwin; Daniel Dimaio; Akiko Iwasaki
Journal:  Virology       Date:  2013-07-18       Impact factor: 3.616

10.  T cell susceptibility to HIV influences outcome of opportunistic infections.

Authors:  Kapil K Saharia; Richard A Koup
Journal:  Cell       Date:  2013-10-24       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.